ChronoScale Corporation Common Stock (NASDAQ:CHRN) Trading 6.1% Higher – Here’s Why

ChronoScale Corporation Common Stock (NASDAQ:CHRN) shares traded up 6.1% during trading on Thursday . The stock traded as high as $21.83 and last traded at $21.77. Approximately 47,575 shares traded hands during trading, a decline of 80% from the average session volume of 233,863 shares. The stock had previously closed at $20.51.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the company. Northland Securities began coverage on ChronoScale Corporation Common Stock in a research report on Friday, September 18th. They set an “outperform” rating and a $32.00 target price on the stock. Weiss Ratings raised ChronoScale Corporation Common Stock from a “sell (d-)” rating to a “sell (d)” rating in a report on Monday, August 24th. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $19.00.

ChronoScale Corporation Common Stock Trading Up 8.1%

The stock’s fifty day simple moving average is $21.30 and its 200-day simple moving average is $17.34. The firm has a market cap of $3.23 billion, a PE ratio of -4.12 and a beta of 0.98. The company has a debt-to-equity ratio of 0.06, a current ratio of 0.51 and a quick ratio of 0.51.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last posted its quarterly earnings data on Wednesday, August 19th. The company reported ($0.12) EPS for the quarter. The company had revenue of $18.40 million for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 197.81% and a negative net margin of 135.66%. On average, sell-side analysts forecast that ChronoScale Corporation Common Stock will post -0.1 earnings per share for the current year.

Institutional Trading of ChronoScale Corporation Common Stock

A hedge fund recently raised its position in ChronoScale Corporation Common Stock stock. Roble Belko & Company Inc raised its position in shares of ChronoScale Corporation Common Stock (NASDAQ:CHRN) by 104.5% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,338 shares of the company’s stock after purchasing an additional 1,195 shares during the quarter. Roble Belko & Company Inc owned 0.07% of ChronoScale Corporation Common Stock worth $25,000 at the end of the most recent reporting period. 6.42% of the stock is owned by hedge funds and other institutional investors.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.